Atlas Trials

Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

Clinical trial NCT03926845 · COMPLETED

Trial details

NCT number
NCT03926845
Sponsor
Institute of Dermatology, Thailand
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Facial Hyperpigmentation
Start date
2019-04-29
Primary completion
2020-11-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.